No Data
No Data
PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 17, 2024, the company approved non-statutory stock options to purchase an...
Express News | PTC Therapeutics Inc : Leerink Partners Raises Target Price to $37 From $28
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones index gaining around 50 points on Friday.Shares of Asana, Inc. (NYSE:ASAN) rose sharply during Friday's session after the company announced a $150 million sh
Jefferies Maintains PTC Therapeutics(PTCT.US) With Buy Rating, Maintains Target Price $46
Jefferies analyst Kelly Shi maintains $PTC Therapeutics(PTCT.US)$ with a buy rating, and maintains the target price at $46.According to TipRanks data, the analyst has a success rate of 31.2% and a tot
BofA Securities Maintains PTC Therapeutics(PTCT.US) With Sell Rating, Maintains Target Price $32
BofA Securities analyst Tazeen Ahmad maintains $PTC Therapeutics(PTCT.US)$ with a sell rating, and maintains the target price at $32.According to TipRanks data, the analyst has a success rate of 44.5%